Revenue surged 54% year-over-year with a return to profitability, driven by strong demand for AI and authentication solutions. Guidance was revised upward, and Admedica was consolidated as a subsidiary, while new performance-linked stock options were issued to the CEO.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.